Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (181-190 of 367) with videos related to

Pageof 37
Sort By:
Wiener Klinische Wochenschrift|August 22, 2018
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleedingThomas Gremmel, Alexander Niessner, Hans Domanovits, et al.
Journal of Thrombosis and Haemostasis : JTH|September 23, 2023
The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disordersDino Mehic, Daniel Kraemmer, Alexander Tolios, et al.
Wiener Klinische Wochenschrift|February 24, 2019
Correction to: Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleedingThomas Gremmel, Alexander Niessner, Hans Domanovits, et al.
Thrombosis and Haemostasis|May 1, 2010
Spectrum of causative mutations in patients with haemophilia A in AustriaSylvia Reitter, Rümuth Sturn, Birgit Horvath, et al.
Research and Practice in Thrombosis and Haemostasis|March 9, 2023
Atrial fibrillation and cancer: prevalence and relative risk from a nationwide studyCihan Ay, Ella Grilz, Stephan Nopp, et al.
Research and Practice in Thrombosis and Haemostasis|September 25, 2025
Prevalence of iron deficiency in patients with mild to moderate bleeding disorders and bleeding disorder of unknown causeTim Dreier, Dino Mehic, Justin Oosterlee, et al.
Journal of Thrombosis and Haemostasis : JTH|February 8, 2025
Platelet function analyzer (PFA-100) in patients with mild-to-moderate bleeding disorders and bleeding disorder of unknown causeDino Mehic, Bernhard Eichinger, Tim Dreier, et al.
Blood|August 27, 2024
Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort studyCornelia Englisch, Florian Moik, Daniel Steiner, et al.
Thrombosis and Haemostasis|March 1, 2005
The Fc gammaRIIa polymorphism R/H131, autoantibodies against the platelet receptors GPIb alpha and Fc gammaRIIa and a risk for thromboembolism in lupus anticoagulant patientsKatharina Schallmoser, Christiane Rosin, Regina Knittelfelder, et al.
Clinical Chemistry|April 1, 2006
Anti-cardiolipin antibodies and overall survival in a large cohort: preliminary reportGeorg Endler, Claudia Marsik, Bernd Jilma, et al.
Pageof 37

Showing results (181-190 of 367) with videos related to

Sort By:
Pageof 37
Wiener Klinische Wochenschrift|August 22, 2018
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleedingThomas Gremmel, Alexander Niessner, Hans Domanovits, et al.
Journal of Thrombosis and Haemostasis : JTH|September 23, 2023
The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disordersDino Mehic, Daniel Kraemmer, Alexander Tolios, et al.
Wiener Klinische Wochenschrift|February 24, 2019
Correction to: Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleedingThomas Gremmel, Alexander Niessner, Hans Domanovits, et al.
Thrombosis and Haemostasis|May 1, 2010
Spectrum of causative mutations in patients with haemophilia A in AustriaSylvia Reitter, Rümuth Sturn, Birgit Horvath, et al.
Research and Practice in Thrombosis and Haemostasis|March 9, 2023
Atrial fibrillation and cancer: prevalence and relative risk from a nationwide studyCihan Ay, Ella Grilz, Stephan Nopp, et al.
Research and Practice in Thrombosis and Haemostasis|September 25, 2025
Prevalence of iron deficiency in patients with mild to moderate bleeding disorders and bleeding disorder of unknown causeTim Dreier, Dino Mehic, Justin Oosterlee, et al.
Journal of Thrombosis and Haemostasis : JTH|February 8, 2025
Platelet function analyzer (PFA-100) in patients with mild-to-moderate bleeding disorders and bleeding disorder of unknown causeDino Mehic, Bernhard Eichinger, Tim Dreier, et al.
Blood|August 27, 2024
Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort studyCornelia Englisch, Florian Moik, Daniel Steiner, et al.
Thrombosis and Haemostasis|March 1, 2005
The Fc gammaRIIa polymorphism R/H131, autoantibodies against the platelet receptors GPIb alpha and Fc gammaRIIa and a risk for thromboembolism in lupus anticoagulant patientsKatharina Schallmoser, Christiane Rosin, Regina Knittelfelder, et al.
Clinical Chemistry|April 1, 2006
Anti-cardiolipin antibodies and overall survival in a large cohort: preliminary reportGeorg Endler, Claudia Marsik, Bernd Jilma, et al.
Pageof 37